121 filings
Page 3 of 7
8-K
711yyjzmuhhhgv
19 Apr 21
LifeMD Announces Expected Record Revenue of $18.2M for Q1’21, Up 323% Vs. Q1’20, Due to Growth in Subscriptions and Patient Acquisition
5:23pm
8-K
iajzn
16 Apr 21
Other Events
5:23pm
8-K
v64nnwg
15 Apr 21
Other Events
5:30pm
8-K
a8n70q dycu
6 Apr 21
Unregistered Sales of Equity Securities
5:21pm
8-K
rsxtxgpvgbhgx527
1 Apr 21
LifeMD Reports Q4 2020 Revenue up 227% to Record $12.9 Million, Full Year up 199% to Record $37.3 Million
10:40am
8-K
1iktg i1d
26 Feb 21
Unregistered Sales of Equity Securities
5:00pm
8-K
2jlzek4kzsq56sddwm
22 Feb 21
Conversion Labs Begins Trading Under New Company Name, LifeMD, and Ticker Symbol, LFMD
7:30am
8-K
n35vow6t33yfdqvv
12 Feb 21
Conversion Labs to Become Life MD™ with Launch of New Concierge Telehealth Services
8:30am
8-K
vl41z7e
10 Feb 21
Conversion Labs Appoints Seasoned Financial and Operational Executive, Marc Benathen, as Chief Financial Officer
4:00pm
8-K
hq91nox 7a
4 Feb 21
Unregistered Sales of Equity Securities
5:00pm
8-K
mh2s983
2 Feb 21
Regulation FD Disclosure
10:10am
8-K/A
a5irexufaqm
28 Jan 21
Conversion Labs Increases Stake in Fast-Growing SaaS Subsidiary
5:30pm
8-K
t4ljnn06rvbtn8i
26 Jan 21
Entry into a Material Definitive Agreement
5:15pm
8-K
1tggku
19 Jan 21
Conversion Labs Expects 2020 Revenue up 205% to Record $38.0 Million, Subscription ARR up 525% to $26.0 Million
4:15pm
8-K
sgg21b1kuganhjahy0
14 Jan 21
Departure of Directors or Certain Officers
4:15pm
8-K
mimribillb
14 Jan 21
Conversion Labs Appoints Leading Telehealth Professional, Dr. Anthony Puopolo, as Chief Medical Officer
4:15pm
8-K
b24w5i lvr9p
11 Jan 21
Conversion Labs Appoints Digital Marketing Executive, Bryant Hussey, as Chief Digital Officer
4:15pm
8-K
8w1o5a8i9eamm8fqdfn9
28 Dec 20
Unregistered Sales of Equity Securities
5:10pm
8-K
19mclciqw8goy
11 Dec 20
Unregistered Sales of Equity Securities
5:25pm
8-K
a01b373k
3 Dec 20
Unregistered Sales of Equity Securities
5:00pm